UNH vs ELV
UNH and ELV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | ELVELEVANCE HEALTH, INC. |
|---|---|---|
| Market cap | $376.36B | $81.51B |
| P/E (TTM) | 31.2 | 16.6 |
| P/B | 11.40 | 1.82 |
| P/S | 0.8x | 0.4x |
| Dividend yield | 2.10% | 1.88% |
| Revenue | $449.71B(TTM) | $201.11B(TTM) |
| Revenue growth (YoY) | 11.8% | 12.5% |
| Net income | $12.04B(TTM) | $4.96B(TTM) |
| Earnings growth (YoY) | -16.3% | -5.3% |
| EPS, diluted | $13.28(TTM) | $22.61(TTM) |
| EBIT margin | 4.2% | 3.6% |
| ROE | 36.5% | 12.6% |
| ROIC | 19.9% | 9.3% |
| 1y total return | +69.5% | +35.3% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: UNH frente a ELV
| Métrica | UNH | ELV |
|---|---|---|
| Valor final | $37.9K | $31.0K |
| Retorno total | +278.6% | +210.0% |
| CAGR | +13.8% | +11.6% |
| Volatilidad | 29.9% | 31.0% |
| Sharpe | 0.46 | 0.39 |
| Sortino | 0.63 | 0.54 |
| Caída máxima | -61.4% | -50.4% |
Basado en 2600 días de negociación comunes, 2016-03-30 → 2026-07-31 · tasa libre de riesgo 3.83% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)